THE EFFECT OF COMBINED RECOMBINANT-HUMAN-ERYTHROPOIETIN AND HYDROXYUREA ON ERYTHROPOIESIS IN BETA-THALASSEMIA-INTERMEDIA

被引:0
|
作者
AKER, M
PERRY, D
DOVER, G
RACHMILEWITZ, EA
机构
[1] HADASSAH UNIV HOSP,JERUSALEM,ISRAEL
[2] JOHNS HOPKINS UNIV,BALTIMORE,MD 21218
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A257 / A257
页数:1
相关论文
共 50 条
  • [1] SUSTAINED INCREASE IN HEMOGLOBIN, HCT, AND RBC FOLLOWING LONG-TERM ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TO PATIENTS WITH BETA-THALASSEMIA-INTERMEDIA
    AKER, M
    DOVER, G
    SCHRIER, S
    RACHMILEWITZ, EA
    BLOOD, 1993, 82 (10) : A358 - A358
  • [2] Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in young β-thalassemia intermedia patients
    Elalfy, Mohsen S.
    Adly, Amira A. M.
    Ismail, Eman A.
    Elhenawy, Yasmine I.
    Elghamry, Islam R.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 91 (06) : 522 - 533
  • [3] TRIAL OF RECOMBINANT-HUMAN-ERYTHROPOIETIN - 3 PATIENTS WITH THALASSEMIA-INTERMEDIA
    OLIVIERI, NF
    FREEDMAN, MH
    PERRINE, SP
    DOVER, GJ
    SHERIDAN, B
    ESSENTINE, DL
    NAGEL, RL
    BLOOD, 1992, 80 (12) : 3258 - 3260
  • [4] Therapeutic Superiority and Safety of Combined Hydroxyurea with Recombinant Human Erythropoietin Over Hydroxyurea in B-Thalassemia Intermedia Patients
    Elalfy, Mohsen Saleh
    Adly, Amira
    Elhanawy, Yassmine
    BLOOD, 2012, 120 (21)
  • [5] SERUM ERYTHROPOIETIN AND ERYTHROPOIESIS IN HIGH-FETAL AND LOW-FETAL HEMOGLOBIN BETA-THALASSEMIA-INTERMEDIA PATIENTS
    GALANELLO, R
    BARELLA, S
    TURCO, MP
    GIAGU, N
    CAO, A
    DORE, F
    LIBERATO, NL
    GUARNONE, R
    BAROSI, G
    BLOOD, 1994, 83 (02) : 561 - 565
  • [6] BENEFICIAL EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN BETA-THALASSEMIA PATIENTS ON DIALYSIS
    COZMA, G
    COZMA, MC
    MATTES, U
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (01) : 82 - 83
  • [7] IMPROVEMENT OF MOUSE BETA-THALASSEMIA BY RECOMBINANT-HUMAN-ERYTHROPOIETIN
    LEROYVIARD, K
    ROUYERFESSARD, P
    BEUZARD, Y
    BLOOD, 1991, 78 (06) : 1596 - 1602
  • [8] THERAPEUTIC BENEFIT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AND HYDROXYUREA IN HEMOGLOBIN-E - BETA-DEGREES-THALASSEMIA SYNDROME
    VADAKAN, V
    SLEIGHT, GW
    VADAKAN, V
    BLOOD, 1994, 84 (10) : A559 - A559
  • [9] MOLECULAR PATHOLOGY OF BETA-THALASSEMIA-INTERMEDIA
    LU, CY
    RAGUSA, A
    GONCALVES, I
    LAPOUMEROULIE, C
    KRISHNAMOORTHY, R
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1993, 35 (03): : 317 - 318
  • [10] Recombinant human erythropoietin trial in thalassemia intermedia
    Nisli, G
    Kavakli, K
    Vergin, C
    Oztop, S
    Cetingul, N
    JOURNAL OF TROPICAL PEDIATRICS, 1996, 42 (06) : 330 - 334